Lambda Biologics' tonsil organoids provide a physiologically relevant in vitro system that closely mimics native tonsil tissue. They serve as powerful models for studying infectious diseases, immune cell interactions, and therapeutic development.
Price | 1435€+ |
Organism | Human |
Product Type | Adult Tissue derived organoid |
Tissue | Tonsil |
Disease | Coronavirus, HPV, Respiratory and ENT Disease |
Applications
Infectious disease research, immunology, respiratory & ENT studies, therapy development
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Leverage our tonsil organoids for in-depth studies on infectious diseases and immune responses.
These models mimic the human tonsil environment, facilitating targeted therapy development and enhancing understanding of immune mechanisms.
Utilize our advanced organoids to accelerate your immunological research and therapeutic discoveries.
Validation of tonsil epithelial markers, such as NGFR, ITGA6, CD44, MUC1, E-cadherin, an Ki67, in organoids through IF/IHC, demonstrating their presence, similar to the tissue.
Tonsil organoids are human-derived 3D models that mimic tonsil epithelial tissue. They are widely used to study viral infections (such as HPV and SARS-CoV-2), respiratory and ENT diseases, and immune responses. These models enable researchers to investigate host – pathogen interactions and evaluate potential therapies in a physiologically relevant system.
Yes. We work closely with academic, biotech, and pharma partners to adapt organoid systems for targeted research needs. Options include co-culture with patient-derived immune cells, integration with stromal elements, and assay development tailored to antiviral, immunotherapy, or vaccine research.
We provide detailed technical data sheets covering differentiation methods, marker expression, and functional validation, so you can trust the reliability and reproducibility of your results.
Our organoids faithfully reproduce tonsil epithelial architecture and marker expression, while also enabling co-culture with immune cells. This provides researchers with a highly predictive platform for investigating immune responses, pathogen entry, and therapeutic strategies in respiratory and ENT-related diseases.
Simply contact Lambda Biologics team. Our scientists will review your project needs and provide the right options whether it’s technical guidance, a quote, or custom organoid development.
